<DOC>
	<DOCNO>NCT00303199</DOCNO>
	<brief_summary>The study safety new organic arsenic compound treatment advance multiple myeloma</brief_summary>
	<brief_title>Study ZIO-101 Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Subjects multiple myeloma receive least two prior therapy currently require therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Arsenic</keyword>
	<keyword>Cancer study</keyword>
	<keyword>Failed treatment</keyword>
</DOC>